14th September 2018
Healthcare at Home is pleased to welcome Peter Nicklin to the Board as non-executive director.
With over 30 years’ operational management experience across a broad international healthcare landscape including pharmaceuticals, biologics, vaccines, medtech and healthcare services, Peter is a valued addition to the Healthcare at Home Board. He has significant global experience in healthcare business development leadership. His previous roles include Corporate Vice President and EMEA President of Baxter International, Board Member of Bayer Healthcare AG and Western and Central Europe lead for Novartis.
Peter is currently CEO and Member of the Board of Amann Girrbach AG, the leading innovator in digital dental prosthetics, based in Koblach, Austria. Additionally, he is Chairman of the Board of Versantis, a Swiss pharmaceutical company developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease.
A Chartered Accountant by training, Peter began his career at PricewaterhouseCoopers, after earning a bachelor’s degree at the University of Lancaster.
Peter commented “I’m pleased to be joining the Healthcare at Home Board at an exciting time in the company’s history as they redefine their long-term strategy. I’m looking forward to lending my expertise and sharing experience from across the healthcare sector, ultimately to enhance patient outcomes.”
Notes to editors:
Please contact our media team at:
T: 0333 207 9871